Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Liver Cancer”

886 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 886 results

Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Testing effectiveness (Phase 2)Study completedNCT00280618
What this trial is testing

Oxaliplatin in Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Sanofi
Testing effectiveness (Phase 2)Study completedNCT00030563
What this trial is testing

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Washington
Testing effectiveness (Phase 2)Study completedNCT04710641
What this trial is testing

Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone

Who this might be right for
Hepatocellular CarcinomaHepatitis BHepatitis C
Mina Alpha Limited 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305
What this trial is testing

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03869034
What this trial is testing

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Study completedNCT00076609
What this trial is testing

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
PhytoCeutica 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Study completedNCT03893695
What this trial is testing

Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)

Who this might be right for
Metastatic Hepatocellular CarcinomaHCCCombinations of Drugs; Dependence
Suzhou Kintor Pharmaceutical Inc, 20
Testing effectiveness (Phase 2)Looking for participantsNCT06792695
What this trial is testing

Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AstraZeneca 80
Testing effectiveness (Phase 2)WithdrawnNCT05039736
What this trial is testing

A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Early research (Phase 1)Looking for participantsNCT07391839
What this trial is testing

MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.

Who this might be right for
HepatomaUnresectable Hepatocellular Carcinoma (HCC)
Suzhou Mednovo Yi Medical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT06364007
What this trial is testing

HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC

Who this might be right for
Hepatocellular Carcinoma
Sulai Liu 20
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Next Page